TY - JOUR
T1 - The androgen 5α-dihydrotestosterone and its metabolite 5α-androstan-3β,17β-diol inhibit the hypothalamo-pituitary- adrenal response to stress by acting through estrogen receptor β-expressing neurons in the hypothalamus
AU - Lund, Trent D.
AU - Hinds, Laura R.
AU - Handa, Robert J.
PY - 2006/2/1
Y1 - 2006/2/1
N2 - Estrogen receptor β (ERβ) and androgen receptor (AR) are found in high levels within populations of neurons in the hypothalamus. To determine whether AR or ERβ plays a role in regulating hypothalamo-pituitary-adrenal (HPA) axis function by direct action on these neurons, we examined the effects of central implants of 17β-estradiol (E2), 5α-dihydrotestosterone (DHT), the DHT metabolite 5α-androstan-3β,17β-diol (3β-diol), and several ER subtype-selective agonists on the corticosterone and adrenocorticotropin (ACTH) response to immobilization stress. In addition, activation of neurons in the paraventricular nucleus (PVN) was monitored by examining c-fos mRNA expression. Pellets containing these compounds were stereotaxically implanted near the PVN of gonadectomized male rats. Seven days later, animals were killed directly from theirhomecage (nonstressed) or were restrained for 30min(stressed) before they were killed. Compared with controls, E2 and the ERα-selective agonists moxestrol and propyl-pyrazole-triol significantly increased the stress induced release of corticosterone and ACTH. In contrast, central administration of DHT, 3β-diol, and the ERβ-selective compound diarylpropionitrile significantly decreased the corticosterone and ACTH response to immobilization. Cotreatment with the ER antagonist tamoxifen completely blocked the effects of 3β-diol and partially blocked the effect of DHT, whereas the AR antagonist flutamide had no effect. Moreover, DHT, 3β-diol, and diarylpropionitrile treatment significantly decreased restraint-induced c-fos mRNA expression in the PVN. Together, these studies indicate that the inhibitory effects of DHT on HPA axis activity maybe in part mediated via its conversion to 3β-diol and subsequent binding to ERβ.
AB - Estrogen receptor β (ERβ) and androgen receptor (AR) are found in high levels within populations of neurons in the hypothalamus. To determine whether AR or ERβ plays a role in regulating hypothalamo-pituitary-adrenal (HPA) axis function by direct action on these neurons, we examined the effects of central implants of 17β-estradiol (E2), 5α-dihydrotestosterone (DHT), the DHT metabolite 5α-androstan-3β,17β-diol (3β-diol), and several ER subtype-selective agonists on the corticosterone and adrenocorticotropin (ACTH) response to immobilization stress. In addition, activation of neurons in the paraventricular nucleus (PVN) was monitored by examining c-fos mRNA expression. Pellets containing these compounds were stereotaxically implanted near the PVN of gonadectomized male rats. Seven days later, animals were killed directly from theirhomecage (nonstressed) or were restrained for 30min(stressed) before they were killed. Compared with controls, E2 and the ERα-selective agonists moxestrol and propyl-pyrazole-triol significantly increased the stress induced release of corticosterone and ACTH. In contrast, central administration of DHT, 3β-diol, and the ERβ-selective compound diarylpropionitrile significantly decreased the corticosterone and ACTH response to immobilization. Cotreatment with the ER antagonist tamoxifen completely blocked the effects of 3β-diol and partially blocked the effect of DHT, whereas the AR antagonist flutamide had no effect. Moreover, DHT, 3β-diol, and diarylpropionitrile treatment significantly decreased restraint-induced c-fos mRNA expression in the PVN. Together, these studies indicate that the inhibitory effects of DHT on HPA axis activity maybe in part mediated via its conversion to 3β-diol and subsequent binding to ERβ.
KW - Dihydrotestosterone
KW - Estrogen receptor
KW - Hypothalamo-pituitary-adrenal axis
KW - Hypothalamus
KW - Rat
KW - Stress
UR - http://www.scopus.com/inward/record.url?scp=32544434363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=32544434363&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.3777-05.2006
DO - 10.1523/JNEUROSCI.3777-05.2006
M3 - Article
C2 - 16452668
AN - SCOPUS:32544434363
SN - 0270-6474
VL - 26
SP - 1448
EP - 1456
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 5
ER -